FOCUS-GSK to boost spending power of pharma business post break-up
* GSK hopes June 23 investor day will mark turnaround for shares* New pharma-focused GSK will slash dividends, cut debt* Analysts encourage GSK to purchase external drug assets* Executive Luke Miels points to upcoming pipeline trial resultsBy Ludwi...
Read more